$178.71
0.99% yesterday
NYSE, Nov 25, 10:01 pm CET
ISIN
US98978V1035
Symbol
ZTS
Sector
Industry

Zoetis, Inc. Class A Stock price

$178.71
-1.30 0.72% 1M
+8.64 5.08% 6M
-18.66 9.45% YTD
-0.08 0.04% 1Y
-44.46 19.92% 3Y
+58.10 48.17% 5Y
+134.80 306.99% 10Y
NYSE, Closing price Mon, Nov 25 2024
+1.75 0.99%
ISIN
US98978V1035
Symbol
ZTS
Sector
Industry

Key metrics

Market capitalization $80.63b
Enterprise Value $85.67b
P/E (TTM) P/E ratio 33.60
EV/FCF (TTM) EV/FCF 37.12
EV/Sales (TTM) EV/Sales 9.36
P/S ratio (TTM) P/S ratio 8.81
P/B ratio (TTM) P/B ratio 15.42
Dividend yield 0.87%
Last dividend (FY23) $1.56
Revenue growth (TTM) Revenue growth 9.33%
Revenue (TTM) Revenue $9.15b
EBIT (operating result TTM) EBIT $3.34b
Free Cash Flow (TTM) Free Cash Flow $2.31b
Cash position $1.71b
EPS (TTM) EPS $5.32
P/E forward 32.58
P/S forward 8.71
EV/Sales forward 9.26
Short interest 0.96%
Show more

Is Zoetis, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Zoetis, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Zoetis, Inc. Class A forecast:

16x Buy
80%
4x Hold
20%

Analyst Opinions

20 Analysts have issued a Zoetis, Inc. Class A forecast:

Buy
80%
Hold
20%

Financial data from Zoetis, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
9,152 9,152
9% 9%
100%
- Direct Costs 2,884 2,884
10% 10%
32%
6,268 6,268
9% 9%
68%
- Selling and Administrative Expenses 1,758 1,758
9% 9%
19%
- Research and Development Expense 674 674
15% 15%
7%
3,836 3,836
9% 9%
42%
- Depreciation and Amortization 500 500
3% 3%
5%
EBIT (Operating Income) EBIT 3,336 3,336
9% 9%
36%
Net Profit 2,430 2,430
7% 7%
27%

In millions USD.

Don't miss a Thing! We will send you all news about Zoetis, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zoetis, Inc. Class A Stock News

Neutral
Seeking Alpha
6 days ago
Zoetis Inc. (NYSE:ZTS ) Jefferies London Healthcare Conference November 20, 2024 10:00 AM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo Thank you for taking the time to join us this afternoon. We're very excited to have Zoetis for our next presentation.
Neutral
Business Wire
7 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 11:30 a.m. ET. Investors and other interested parties will be able to acces...
Positive
Seeking Alpha
8 days ago
Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO, outperforming the S&P 500. The company benefits from increasing global pet ownership and spending, making its revenues less susceptible to economic downturns. Zoetis boasts a strong competitive moat with a diverse product portfolio, significant patent protection, and consistent R&D investment.
More Zoetis, Inc. Class A News

Company Profile

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Head office United States
CEO Kristin Peck
Employees 14,100
Founded 1952
Website www.zoetis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today